Marquette Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Buy
+33
New +$12.2K ﹤0.01% 288
2026
Q1
Sell
-32
Closed -$11.2K 830
2025
Q4
$11.2K Buy
32
+11
+52% +$3.72K ﹤0.01% 217
2025
Q3
$6.79K Buy
+21
New +$6.53K ﹤0.01% 277
2022
Q3
Sell
-1
Closed 280
2022
Q2
$0 Hold
1
﹤0.01% 336
2022
Q1
$0 Buy
+1
New +$457 ﹤0.01% 364

Other funds holding ELV

Marquette Asset Management's ELV Position: Q2 2026 in Review

Marquette Asset Management opened a new position in Elevance Health (ELV) in Q2 2026: 33 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #288 among its holdings. This is a return to the name: Marquette Asset Management previously reported a position in ELV as recently as Q4 2025.

Marquette Asset Management first reported a position in ELV in Q1 2022 and has held it in 5 quarters since. 582 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Marquette Asset Management held 33 shares of Elevance Health worth $12.8K as of Q2 2026.
  • Elevance Health was a new Marquette Asset Management position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #288 holding.
  • Marquette Asset Management first reported a position in Elevance Health in Q1 2022 and has held it in 5 quarters since.
  • 582 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.